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Abstract
A subset of patients with stable asthma has prominent neutrophilic and reduced eosinophilic inflammation, which is
associated with attenuated airways hyper-responsiveness (AHR). Haemophilus influenzae has been isolated from the airways
of neutrophilic asthmatics; however, the nature of the association between infection and the development of neutrophilic
asthma is not understood. Our aim was to investigate the effects of H. influenzae respiratory infection on the development
of hallmark features of asthma in a mouse model of allergic airways disease (AAD). BALB/c mice were intraperitoneally
sensitized to ovalbumin (OVA) and intranasally challenged with OVA 12–15 days later to induce AAD. Mice were infected
with non-typeable H. influenzae during or 10 days after sensitization, and the effects of infection on the development of key
features of AAD were assessed on day 16. T-helper 17 cells were enumerated by fluorescent-activated cell sorting and
depleted with anti-IL-17 neutralizing antibody. We show that infection in AAD significantly reduced eosinophilic
inflammation, OVA-induced IL-5, IL-13 and IFN-c responses and AHR; however, infection increased airway neutrophil influx
in response to OVA challenge. Augmented neutrophilic inflammation correlated with increased IL-17 responses and IL-17
expressing macrophages and neutrophils (early, innate) and T lymphocytes (late, adaptive) in the lung. Significantly,
depletion of IL-17 completely abrogated infection-induced neutrophilic inflammation during AAD. In conclusion, H.
influenzae infection synergizes with AAD to induce Th17 immune responses that drive the development of neutrophilic and
suppress eosinophilic inflammation during AAD. This results in a phenotype that is similar to neutrophilic asthma. Infection-
induced neutrophilic inflammation in AAD is mediated by IL-17 responses.
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Introduction
Asthma is a complex disease of the airways that is generally
characterized by symptoms of wheeze, cough, breathlessness and
airway inflammation. While eosinophilic inflammation has been
considered to be the hallmark of airway inflammation in asthma
[1,2], it is present in only 50% of asthmatics [3]. Non-eosinophilic
asthma has now been described in persistent [4,5] and severe
asthma, [6] as well as in steroid naı ¨ve asthma [7]. Further
investigation of the non-eosinophilic subtype has identified a
subgroup with an intense neutrophilic bronchitis [5,8] with
increased interleukin (IL)-8 [4]. Compared to eosinophilic asthmat-
ics, neutrophilic asthmatics have reduced eosinophilic inflammation
and AHR. Furthermore, they are frequently resistant to corticoste-
roid treatment, which results in a significant proportion of asthma-
related health care costs [5,8,9,10,11,12]. IL-17 is also elevated in
asthma and other obstructive airway diseases that are characterized
by increased neutrophils [13,14,15,16].
IL-8 and IL-17 are important mediators of neutrophilic inflam-
mation during infection and in disease states [4,12,13,17,18] and
their elevated expression in neutrophilic asthma correlates with
increased levels of neutrophils in sputum [15]. IL-8 is a potent
neutrophil chemoattractant, produced by macrophages, lympho-
cytes, epithelial cells and neutrophils [19,20]. IL-17 is produced by
several cells including Th17 cells [21,22,23], cd T cells [24,25],
neutrophils [26], and macrophages [27,28]. IL-17 has critical roles
in host defence against bacterial infections [29,30,31,32], suggest-
ing a potential role in the pathogenesis of bacterial-induced
neutrophilic asthma.
Chronic bacterial colonization is evident in the airways of
patients with neutrophilic asthma [12] and is also associated with
an intense neutrophilic bronchitis in asthma [33]. H. influenzae is a
common bacterium of the respiratory tract, is one of the bacteria
most frequently isolated from the airways of neutrophilic
asthmatics [12,33], and often causes recurrent respiratory disease
[34,35,36] in those with compromised airways. Nevertheless, how
H. influenzae is associated with the pathogenesis of neutrophilic
asthma is unknown. Specifically, whether infection promotes the
pathogenesis of neutrophilic asthma, or if neutrophilic asthmatics
are predisposed to infection is not known.
In this study we used murine models of H. influenzae infection and
OVA-induced allergic airways disease, which mimics hallmark
features of human asthma, to elucidate the potential association
between infection and the development of neutrophilic asthma.
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Non-typeable Haemophilus influenzae infection
In order to investigate the association between H. influenzae lung
infection and asthma we first established and characterized a
murine model of NTHi lung infection alone. Inoculation
intratracheally (i.t.) with 5x10
5 CFU of NTHi resulted in a mild
respiratory infection that induced inflammatory responses but did
not significantly affect lung function (Figure 1).
Bacterial numbers in bronchoalveolar lavage fluid (BALF) and
lung homogenates peaked at 5 days and were cleared 16 days after
inoculation (Figure 1A). NTHi infection induced airway inflam-
mation. Neutrophil influx into the airways peaked at 24 hours
post-infection while lymphocytes and eosinophils were significantly
increased at 5 days. Neutrophil numbers returned to baseline after
5 days, while lymphocyte and eosinophil numbers returned to
baseline after 10 days post-infection (Figure 1B). Infection also
induced significant but low level increases in NTHi-induced IL-5,
IL-13, IL-17 and IL-22, and higher levels of IFN-c release from
mediastinal lymph nodes (MLN) cultures after 5 days, which
returned to baseline levels after 26 days (Figure 1C). Infection did
not affect lung function, with no changes in AHR (dynamic
compliance or transpulmonary resistance in response to increasing
doses of methacholine) compared to sham infected (Saline)
controls 5, 16 and 26 days after inoculation (Figure 1D–E).
NTHi infection suppresses key features of Th2-driven
eosinophilic AAD
To investigate the effect of infection on AAD in sensitized
animals, groups were infected during (d0 NTHi+OVA) or 10 days
after (d10 NTHi+OVA) OVA sensitization (Figure 2A), and AAD
assessed on day 16. Infection suppressed OVA-induced T cell
cytokine responses, inflammatory cell influx and AHR in AAD
(Figure 2).
The development of AAD (OVA groups) resulted in increased
OVA-induced release of IL-5, IL-13 and IFN-c from MLN and
splenic T cells, eosinophilic inflammation and AHR (decreased
compliance and increased resistance in response to methacholine),
compared to uninfected, nonallergic (Saline) controls (Figure 2B–F
and Figure 3). Infection during (d0 NTHi+OVA) or after (d10
NTHi+OVA) sensitization resulted in significant reductions in
OVA-induced IL-5, IL-13 and IFN-c release from MLN T cells
(Figure 2B), compared to uninfected, allergic (OVA) controls.
Infection also significantly reduced the numbers of total cells and
eosinophils in the airways and blood (Figure 2C-D). The reduction
in eosinophils correlated with the reduced release of IL-5 from
MLN T cells. Infection significantly suppressed, but did not
abolish AHR in AAD. Infection during sensitization (d0
NTHi+OVA) had no effect on compliance, but significantly
reduced resistance of the lungs. However, infection after
sensitization (d10 NTHi+OVA), significantly suppressed both
compliance and resistance (Figure 2E–F). Notably, compliance
remained decreased in infected, allergic (NTHi+OVA) groups
compared to uninfected, nonallergic (Saline) controls.
NTHi infection suppresses systemic responses in AAD
Infection during (d0 NTHi+OVA) or after (d10 NTHi+OVA)
sensitization had no effect on systemic IL-5 (Figure 3A) but
significantly reduced systemic IL-13 and IFN-c release from
splenocytes (Figure 3B–C), compared to uninfected, allergic
(OVA) controls.
T regulatory cells (Tregs) are not involved in the
suppression of AAD
To determine if Tregs were involved in the suppression of AAD,
Tregs, TGF-b and IL-10 were quantified on day 16 of the model.
TGF-b and IL-10 are critical immunosuppressive factors that are
produced by Tregs. NTHi infection during and after sensitization
did not alter the numbers of Tregs (Figure 4A) in the lung,
compared to uninfected allergic controls. Notably, infection
decreased the expression of TGF-b (Figure 4B) and IL-10
(Figure 4C) in lung tissue in infected, allergic groups compared
to uninfected, allergic controls.
Infection reduced markers of antigen presentation and
co-stimulation in the suppression of AAD
To determine if alterations in antigen-presenting cells were
involved in the suppression of AAD, the effect of infection on
MHCII and CD86 expressing DCs was also investigated (on day
16). The development of AAD resulted in increases in the numbers
and proportions of MHCII expressing plasmacytoid DCs (pDCs)
and myeloid DCs (mDCs), and CD86 expressing MHCII+ pDCs
and mDCs in MLNs and lungs (Figure 5A–H), compared to
uninfected, nonallergic controls. Infection during or after sensiti-
zation resulted in significant decreases in MHCII and CD86
expressing pDCs and mDCs compared to uninfected, allergic
controls (Figure 5A–H).
Infection enhances neutrophilic inflammation in AAD
We then assessed the effects of infection on other features of
AAD (on day 16). Significantly, whilst eosinophilic inflammatory
responses were suppressed by infection during AAD, NTHi
infection induced AAD with an enhanced neutrophilic inflamma-
tory profile.
The development of AAD resulted in an increase in neutrophil
influx into the airways (Figure 6). Infection during or after
sensitization resulted in a two-fold increase in neutrophil
recruitment in BALF compared to uninfected, allergic controls.
Moreover, infected allergic groups had a four-fold increase in
neutrophil recruitment compared to groups with infection alone
(i.e. infected, nonallergic groups) at the same time point after
infection (i.e. 16d and 5d after infection, Figure 6). These results
Author Summary
Approximately 50% of asthmatics have non-eosinophilic
inflammation, and 20% of these patients have severe
neutrophilic inflammation and increased IL-8 levels. These
so-called neutrophilic asthmatics have persistent airway
colonization with bacteria, and Haemophilus influenzae is
one of the bacteria most commonly isolated. However,
how H. influenzae is associated with the pathogenesis of
neutrophilic asthma is unknown. In this study we used
mouse models to investigate the relationship between H.
influenzae infection and allergic airways disease (AAD). We
showed that infection promoted the development of
hallmark features of neutrophilic asthma. Infection sup-
pressed Th2 cytokines, eosinophilic inflammation, and AHR
in AAD, while increasing neutrophilic inflammation and IL-
17 responses. Importantly, inhibition of IL-17 during AAD
reduced airway neutrophils and neutrophil chemokines,
suggesting that infection drives the development of
neutrophilic inflammation through an IL-17-mediated
mechanism. This provides novel insights into the mecha-
nisms that may underpin infection-induced neutrophilic
asthma. These data also suggest that treatments targeting
infection may lead to improved management of neutro-
philic asthma.
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PLoS Pathogens | www.plospathogens.org 2 October 2011 | Volume 7 | Issue 10 | e1002244Figure 1. Characterization of NTHi infection. The profile of infection was assessed in mice that only received NTHi (i.e. not OVA), by performing
a time-course of bacterial recovery from BALF and lung homogenates (A), and airway inflammation represented by BALF neutrophils, lymphocytes
and eosinophils (B). IL-5, IL-13, IL-17, IL-22 and IFN-c (C) release from MLN T cells stimulated with killed NTHi compared to unstimulated cells was also
determined. Lung function in terms of AHR (dynamic compliance (D) and transpulmonary resistance (E)) in response to increasing doses of
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enhanced neutrophilic inflammation. Collectively, our results
show that NTHi infection in AAD may induce a phenotype of
neutrophilic AAD that resembles neutrophilic asthma in humans.
Infection-induced neutrophilic inflammation is
associated with increases in IL-17 responses
Neutrophilic inflammation in asthma has been linked with
increased IL-17 expression and IL-17 has been shown to be
involved in neutrophil recruitment in response to bacterial
infection. Therefore, the effects of infection on IL-17 responses
during infection-induced neutrophilic AAD were further investi-
gated. The experiments described hereafter were performed with
infection during (d0 NTHi+OVA) OVA sensitization.
The profile of neutrophil influx into the airways and IL-17
production was determined in lung tissue and MLNs during the
development of infection-induced neutrophilic AAD (1, 5, 12 and
16d, Figure 7A). The development of AAD resulted in increases in
neutrophilic influx into the airways on day 12 and 16, and had
minimal effects on IL-17 responses. Significantly greater numbers
of neutrophils were recruited into the airways during infection and
OVA sensitization (1d) and after OVA challenge (16d) in infected,
allergic compared to uninfected, allergic groups (Figure 7B).
Importantly, increases in the infection-induced neutrophil influx
were accompanied by significant increases in IL-17 responses in
pulmonarytissue andMLNT cells.Theexpressionof IL-17mRNA
in lung tissue was significantly elevated 1 day after infection in
infected, allergic groups (Figure 7C) and returned to baseline levels
by day 12, immediately prior to OVA challenge. Expression again
significantly increased on day 16, after OVA challenges.
NTHi-induced IL-17 release from MLN T cells was also
increased from days 5 to 16 in infected, allergic compared to
uninfected, allergic groups (Figure 7D). Interestingly, infection did
not affect OVA-induced IL-17 release (Figure 7E). Taken together,
these data demonstrate that infection induces increased IL-17
responses in lung tissue and MLNs that correlate with elevated
airway neutrophil numbers in infection-induced neutrophilic AAD.
Infection-induced early influx of neutrophils is associated
with early increases in neutrophil chemokine responses
IL-17 can induce neutrophilic inflammation by enhancing the
expression of the chemotactic factor IL-8. Therefore, the mRNA
expression and protein levels of KC and MIP2, the mouse
orthologs of IL-8, in lung tissue were also investigated. KC and
MIP2 mRNA and protein were elevated 1 day after infection and
OVA sensitization in the lungs of infected, allergic, compared to
uninfected, allergic groups, (Figure 8A–B). There were no
differences in mRNA expression between groups at later time
points. Therefore, the early induction of neutrophil influx into the
lung during the development of infection-induced neutrophilic
AAD is associated with early increases in neutrophil chemokine
responses during infection.
Infection induces Th17 cell differentiation and IL-17
production from Th17 cells
To investigate the mechanisms that underpin infection-induced
neutrophilic AAD, we assessed the potential cellular sources of IL-
17 and the role of adaptive and innate immune cells in its release.
The development of AAD resulted in modest increases in IL-17
factors and responses (Figure 9A–E). ROR-ct, the Th17
differentiation factor was assessed, and expression was significantly
elevated after 12 and 16 days in the lungs of infected, allergic,
compared to uninfected, allergic groups (Figure 9A), suggesting
that there was enhanced Th17 polarization. The numbers and
proportions of T cells that were Th17 cells in lung tissue and
MLNs were then determined by flow cytometry. CD3
+CD4
+IL-
17
+ (Th17) cells were significantly increased in the lungs after 12
and 16 days in infected, allergic groups (Figure 9B–C), but in the
MLNs were increased only at day 5 (Figure 9D–E). These results
indicate that Th17 cells in the lungs and MLNs may be the
potential adaptive immune source of IL-17 after day 5.
Infection induces IL-17 production from macrophages
and neutrophils
We then assessed which cells were the early innate sources of IL-
17 on day 1. Increased numbers and proportions of pulmonary
macrophages (Figure 10A–B) and to a lesser extent neutrophils
(Figure 10C–D) produced increased amounts of IL-17 at early but
not other time-points in infected, allergic groups compared to
uninfected, allergic controls. Lung macrophages and neutrophils
isolated on day 1 also had increased levels of IL-17 mRNA
transcripts (Figure 10E–F).
Taken together these results demonstrate that infection induces
early IL-17 responses from lung macrophages and neutrophils and
later responses from Th17 cells in lungs and MLNs that are
associated with neutrophil influx into the airways.
NTHi-induced neutrophilic AAD is dependent on IL-17
We have shown that neutrophilic inflammation in infection-
induced neutrophilic AAD correlates with increased expression of
IL-17 during OVA challenge. To determine whether infection-
induced neutrophilic inflammation is mediated by IL-17, IL-17
was depleted in infected, allergic groups during AAD, by
administration of anti-IL-17 monoclonal antibody during OVA
challenge on days 11 and 13 (Figure 11A), and AAD assessed (on
day 16). This approach has previously been shown to deplete IL-
17 in vivo [21]. Importantly, IL-17 depletion significantly reduced
the numbers of neutrophils in the BALF compared to isotype
treatment of infected, allergic groups (Figure 11B). Significantly,
neutrophil numbers were not different to those observed in
uninfected, allergic groups, which were unaffected by treatment.
IL-17 depletion also significantly reduced KC mRNA expression
levels in the lung, but had no effect on MIP2 mRNA (Figure 11C).
Anti-IL-17 treatment of infected, allergic groups also partially
restored IL-5 (3.19860.679 ng/ml in anti-IL-17 compared to
1.57660.238 ng/ml in isotype-treated infected allergic groups
p,0.01) and IL-13 (18.24061.533 ng/ml in anti-IL-17 compared
to 11.98860.938 ng/ml in isotype-treated infected allergic groups
p,0.01) responses, but had no affect on IFN-c release. These
results demonstrate that infection-induced IL-17 release is
responsible for neutrophil influx into the airways and the induction
of neutrophilic AAD.
Discussion
In this study we have demonstrated for the first time that H.
influenzae respiratory infection drives IL-17-mediated development
methacholine was assessed 5, 16 and 26 days after inoculation. N.B. P values for compliance and resistance were determined for the entire dose
response curve, *** p,0.001, ** p,0.01, * p,0.05 compared to indicated time points, +++ p,0.001, ++ p,0.01, + p,0.05 compared to unstimulated
controls.
doi:10.1371/journal.ppat.1002244.g001
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PLoS Pathogens | www.plospathogens.org 4 October 2011 | Volume 7 | Issue 10 | e1002244Figure 2. NTHi infection suppressed key features of Th2-driven eosinophilic AAD. Groups of mice were infected during (d0 NTHi+OVA) or
10 days after (d10 NTHi+OVA) OVA sensitization (A), and AAD was analyzed (on day 16). The effects of infection on IL-5, IL-13, and IFN-c (B) release
from MLN T cells stimulated with OVA, BALF total cell and eosinophil counts (C) and the percentage of blood eosinophils (D) were assessed. AHR in
terms of dynamic compliance (E) and transpulmonary resistance (F) was determined (see figure 1D-E for infection only AHR results). Data for the
corresponding NTHi control groups were obtained at the same time point after infection as data from the NTHi+OVA groups. N.B. P values for
H. influenzae in Neutrophilic Airways Disease
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systemic eosinophilic inflammation and reduced Th2 cytokine
responses and AHR in AAD. However, infection induced
neutrophilic inflammation during AAD, by promoting early
(innate) and late (adaptive) IL-17 responses from pulmonary
macrophages and Th17 cells, respectively. This indicates that H.
influenzae infection may modulate immune responses in asthmatics
that promote the development of neutrophilic asthma.
NTHi is commonly isolated from the nasopharynx of healthy
individuals, but is also associated with chronic airway diseases such
as bronchiectasis [37], COPD [38], and chronic bronchitis [39].
NTHi is the bacterium most commonly isolated during COPD
exacerbations, and NTHi strains isolated during these exacerba-
tions induce higher levels of IL-8, and subsequent neutrophil
recruitment to the airways, than colonizing strains [40]. Simpson
and colleagues have recently demonstrated that a large proportion
of neutrophilic asthmatics are colonized with H. influenzae, have
increased innate immune activation, and 6-8 fold higher endotoxin
levels compared to other asthma subtypes and healthy controls
[12]. A more recent study has demonstrated that 41% of
neutrophilic asthmatics assessed had a significant load of
potentially pathogenic bacteria, and H. influenzae was identified
in 60% of patients that tested positive for these bacteria [33]. We
have extended these studies to show that H. influenzae may promote
neutrophilic asthma by suppressing Th2-mediated responses that
are associated with alterations in antigen-presenting cells, and by
inducing potent neutrophilic inflammation that is driven by Th17
responses.
We show that infection during and after sensitization inhibits
characteristic features of eosinophilic asthma. Irrespective of the
compliance and resistance were determined for the entire dose response curve, ### p,0.001, ## p,0.01, # p,0.05 compared to Saline controls,
*** p,0.001, ** p,0.01, * p,0.05 compared to OVA controls.
doi:10.1371/journal.ppat.1002244.g002
Figure 3. NTHi infection suppressed systemic IL-13 and IFN-c responses in AAD. Groups of mice were infected during (d0 NTHi+OVA) or 10
days after (d10 NTHi+OVA) OVA sensitization, and AAD was analyzed (on day 16). The effect of infection on IL-5 (A), IL-13 (B), and IFN-c (C) release
from splenocytes stimulated with OVA was assessed. Data for the corresponding NTHi control groups were obtained at the same time point after
infection as data from the NTHi+OVA groups. ### p,0.001, ## p,0.01 compared to Saline controls, *** p,0.001, * p,0.05 compared to OVA
controls.
doi:10.1371/journal.ppat.1002244.g003
Figure 4. NTHi infection does not affect T regulatory cells in the suppression of AAD. Treg numbers in the lung (A), TGF-b (B) and IL-10 (C)
mRNA expression in lung tissue were assessed (on day 16). Data for the corresponding NTHi control groups were obtained at the same time point
after infection as data from the NTHi+OVA groups. ## p,0.01, compared to Saline controls, ** p,0.01, * p,0.05 compared to OVA controls.
doi:10.1371/journal.ppat.1002244.g004
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systemic allergen-induced cytokine release from MLNs and
splenocytes, as well as airway and blood eosinophil recruitment.
All of these effects may lead to the suppression of AHR. Tregs are
an important cell involved in immune tolerance and the
suppression of inflammation [41]. We show that Treg numbers
were not changed by infection, and TGF-b and IL-10 expression
in the lung, which are involved in the suppression of inflammation
by Tregs, were reduced by infection in AAD. These results suggest
that Tregs are not involved in the suppression of cytokines or
cellular inflammation. The role of infection on DC function was
investigated as DCs play an integral role in the uptake and
presentation of antigen to naı ¨ve T cells, and as a result direct
immune responses [42]. Infection significantly decreased markers
associated with antigen presentation and co-stimulation of DCs.
Therefore, infection is able to alter the phenotype of antigen-
Figure 5. NTHi infection reduced markers of antigen presentation and activation in AAD. The numbers and proportions of MHCII and
CD86 expressing pDCs (A–D) and mDCs (E–H) in MLNs and lungs were determined. Data for the corresponding NTHi control groups were obtained at
the same time point after infection as data from the NTHi+OVA groups. ###p,0.001, ## p,0.01, # p,0.05 compared to Saline controls,
***p,0.001, ** p,0.01, * p,0.05 compared to OVA controls.
doi:10.1371/journal.ppat.1002244.g005
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and T cells, and result in attenuated adaptive responses to allergen.
By contrast, NTHi infection induced potent neutrophilic
inflammation in the airways. Persistent airway neutrophilia is also
a feature common to chronic airway diseases, such as COPD [38],
chronic bronchitis [39] and bronchiectasis [43], where recurrent
infection is known to play an important role in pathogenesis.
Neutrophilic inflammation is often associated with acute asthma
exacerbations, and in particular infection-mediated exacerbations.
Indeed, several studies have shown increased neutrophilic
inflammation in both viral and bacterial infection-induced
exacerbations [44,45,46]. Here we show that NTHi induces
strong neutrophilic inflammatory responses, and may be involved
in the development of neutrophilic asthma through the induction
of neutrophilic inflammation. We demonstrate that immune
responses that lead to the development of NTHi-induced
neutrophilic AAD occur in two phases. The first involves innate
immune activation during infection that is likely to result in
neutrophil chemoattraction to the airways. NTHi infection during
OVA sensitization resulted in a significant neutrophil influx to the
airways 1 day after infection, a two-fold increase compared to
NTHi infection alone. This correlated with the early production of
KC, MIP2 and IL-17 in the lungs. These neutrophils and to a
greater extent macrophages were able to produce significantly
more IL-17 than those from infected, nonallergic and uninfected
allergic controls. Therefore these cells, particularly macrophages,
may be sources of early (innate) IL-17 release. This observation
may have important implications for other diseases where the
innate source of IL-17 has not yet been identified.
The second phase involves adaptive immune responses during
allergen challenge resulting in increased infection-mediated Th17
responses. During the challenge phase, days 12-15, there was a
significant upregulation of ROR-ct and IL-17 mRNA in the
lungs of infected allergic groups compared to infected, nonallergic
and uninfected allergic controls. These results directly correlated
with increases in Th17 cells in the lungs of infected, allergic
groups. The increased production of IL-17 from T cells in
conjunction with increases in ROR-ct expression suggest that
infection drives Th17 responses that preferentially induce IL-17
production and neutrophilic inflammation during subsequent
allergen challenge.
Collectively, our data suggest that infection induces early
responses, involving neutrophils, KC, MIP2 and IL-17 expression
that may prime the host for enhanced Th17-mediated neutrophilic
responses upon later allergen challenge, which subsequently
induces neutrophilic AAD. Our findings are consistent with data
from a recent study by Bullens et al., which showed that increased
IL-17 responses in asthmatics correlate with increased neutrophil
numbers in sputum [15]. Hellings et al., [21] demonstrated that IL-
17 is important in lung neutrophil recruitment in response to an
allergen, while Ye et al., [29] showed that IL-17 responses and
signalling through the IL-17R is vital for neutrophil recruitment
and host defence against Klebsiella pneumoniae infection. Here we
extend these findings by demonstrating that H. influenzae infection-
induced IL-17 responses in AAD may play a role in driving
neutrophilic inflammation in asthma. We recently demonstrated
that chlamydial respiratory infection is also able to drive
neutrophilic asthma [47]. Chlamydial infection suppressed Th2-
mediated eosinophilic inflammation and promoted neutrophilic
inflammation and AAD. Neutrophilic asthmatics are resistant to
corticosteroid treatment, which is the mainstay of asthma therapy
[10], and with evidence that asthmatics with infection are more
resistant to steroids than asthmatics with no infection [48],
alternative therapies are needed for infection-induced neutrophilic
asthma.
It is possible that either infection alone or the synergistic effects
of infection and AAD are required for the induction of the
neutrophilic AAD phenotype. NTHi infection alone did increase
neutrophil influx into the airways (p,0.01), IL-17 mRNA
expression in the lung (p,0.05) and the percentages of lung
macrophages and neutrophils producing IL-17 (both p,0.001) 1
day after infection, compared to uninfected, nonallergic (Saline)
controls. These effects would be expected as they are normal
responses to infection; however, they may contribute to the
establishment of a pro-neutrophilic environment and the subse-
quent development of neutrophilic AAD upon allergen challenge.
However, NTHi infection does not persist past 10 days, and yet is
able to modify AAD after 16 days. It is, therefore, likely that the
major affect of the infection is to induce persistent immune
changes, that continue even after the clearance of the infection,
that synergize with allergen exposure to drive neutrophilic AAD.
This mechanism has recently been proposed in humans [49].
OVA sensitization at the time of, or prior to, infection, and
subsequent OVA challenge does not affect NTHi load. When
infection occurs duringsensitization, bacteria arestill cleared by day
16, and; when infection occurs 10 days after sensitization, bacterial
recovery at the end of the protocol (i.e. 5 days later), is the same as
that in the infected, non-allergic group (data not shown).
It is likely that the induction of a neutrophilic phenotype is
specific to a subset of infectious agents, particularly NTHi and
Chlamydia [12,33,50]. In other studies we have investigated the
impact on AAD of an unrelated respiratory pathogen and
commensal bacterium, Streptococcus pneumoniae, which is not
associated with neutrophilic asthma. We show that S. pneumoniae
infection or components do not induce changes in IL-17 responses
or increase neutrophilic inflammation with infection or component
administration either before, during or after the induction of AAD
[51,52]. Both NTHi- and Chlamydia-induced neutrophilic AAD,
may potentially be driven by conserved pathogen-associated
molecular patterns (PAMPs), such as lipopolysaccharide (LPS) or
CpGs. Numerous studies have investigated the effects of LPS and
CPG in AAD, and the interactions are complex. LPS is highly
variable and different types and levels of LPS have different effects
in AAD. Low dose LPS administration during sensitization
promotes Th2 responses and is a risk factor for severe asthma
Figure 6. NTHi infection induces neutrophilic inflammation in
AAD. The effect of NTHi infection on BALF neutrophil numbers in AAD
was determined (on day 16) and compared to groups with AAD without
infection or infection alone without AAD. Data for the corresponding
NTHi control groups were obtained at the same time point after
infection as data from the NTHi+OVA groups. ## p,0.01 compared to
Saline controls, ** p,0.01 compared to OVA controls.
doi:10.1371/journal.ppat.1002244.g006
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eosinophilic inflammation [55,56,57,58]. Chlamydia-derived LPS is
atypical and is 1,000 fold less immunogenic compared to other
bacterial-derived LPS [59], and therefore, is unlikely to be the
cause of Chlamydia-induced neutrophilic AAD. CpGs when given
together with antigen in established disease induce Th1 and
regulatory T cell responses that suppress the features of AAD
including Th2 responses and AHR [60,61,62]. We have shown
that depleting neutrophils during a Chlamydia infection inhibits the
development of neutrophilic AAD, by contrast IL-17 responses
drive NTHi-induced neutrophilic AAD. Therefore, we suggest
that it is specific immune responses to these, as well as potentially
other infections, which are driven by as yet unidentified factors in
the infections, that are the mechanisms that drive neutrophilic
AAD [47]. Our studies do not rule out LPS, CpGs, or other
PAMPs as drivers of the neutrophilic phenotype and further
research is required to elucidate this possibility.
Importantly we have shown that infection-induced neutrophilic
AAD and the suppression of Th2 responses are dependent upon
IL-17. Depletion of IL-17 with anti-IL-17 monoclonal antibody
during AAD prevented the development of infection-induced
neutrophilic AAD. This suggests that IL-17 is critical in the
recruitment of neutrophils and may suppress Th2 responses in
infection-induced neutrophilic inflammation and neutrophilic
asthma. Wakashin et al., demonstrated that adoptive transfer of
antigen-specific Th17 cells induced airway neutrophil recruitment,
which supports our data [63]. Little is known about how Th17 and
Th2 cells interact with or regulate each other. We demonstrate
Figure 7. NTHi infection induces increased IL-17 responses that correlate with neutrophil influx in neutrophilic AAD. To investigate
the association between neutrophil influx and IL-17 responses, a time-course (A), of neutrophils in BALF (B), IL-17 mRNA expression in lung tissue (C),
and IL-17 release from MLN T cells stimulated with killed NTHi (D), and OVA (E) was assessed. Data for the corresponding NTHi control groups were
obtained at the same time point after infection as data from the NTHi+OVA groups. ### p,0.001, # p,0.05 compared to Saline controls,
*** p,0.001, ** p,0.01, * p,0.05 compared to OVA controls.
doi:10.1371/journal.ppat.1002244.g007
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allergic controls, and that anti-IL-17 treatment partially restored
these effects, while having no effect on eosinophil recruitment
(data not shown). This suggests that other mechanisms are also
involved in the suppression of Th2 responses by NTHi infection,
which requires further investigation. Several recent studies have
investigated the relationship between Th17 and Th2 cells.
Schnyder-Candrian et al., showed that the administration of rIL-
17 in a murine model of AAD significantly reduced allergen-
induced eotaxin, thymus and activation-regulated chemokine
(TARC) and IL-5, thereby reducing eosinophilic inflammation
[64], while another study showed that inhibiting IL-17 in AAD
also reduced airway eosinophils, neutrophils, AHR, and Th2
cytokines [65]. These data suggest that IL-17 may suppress or
promote eosinophilic inflammation, but the mechanisms that drive
these different effects remain unknown. Our data is in agreement
with Schnyder-Candrian et al., who suggest that IL-17 interferes
with DC activation and antigen uptake, which prevents T cell
activation and reduced IL-4, -5 and -13 production, leading to
suppressed allergic responses. Interestingly, a recent study has
shown a CD4
+ T cell subtype that expresses both Th17 and Th2
cytokines, including IL-4, IL-5, IL-13, IL-17 and IL-22, and this
subset is increased in asthmatics compared to healthy controls
[66]. However, these cells have thus far only been found in the
periphery, and confirmation of their presence is needed in BAL,
sputum and/or bronchial biopsies.
In conclusion, we show that H. influenzae infection may be
involved in the development of neutrophilic asthma. Infection
suppressed features of Th2-mediated eosinophilic AAD, while
inducing features of neutrophilic asthma that are mediated by
infection-induced IL-17. Therefore, infection-induced IL-17
responses may play a major role in the pathogenesis of
neutrophilic asthma. Our studies indicate the important role of
infection in driving neutrophilic asthma-like disease, and identify
new areas of investigation that may enhance the understanding of
disease progression. Developing new treatments targeting infection
may lead to better management of individuals with this disease
phenotype.
Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the NSW Animal Research Regulation 2005,
and the Australian Code of Practice for the care and use of
animals for scientific purposes (National Health and Medical
Research Council). All protocols were approved by the Animal
Care and Ethics Committee of the University of Newcastle (permit
number 987/0111). All surgery was performed under sodium
pentobarbital anaesthesia, and all efforts made to minimize pain
and suffering.
AAD model
Six to eight week old female BALB/c mice were used. Mice
were sensitized by intraperitoneal (i.p.) injection, with OVA
(50 mg, Sigma-Aldrich, Castle Hill, NSW, Australia) with the Th2-
inducing adjuvant Rehydrogel (1mg, in 200 ml sterile saline,
Reheis, Berkeley Heights, USA). On days 12 to 15 mice were
challenged intranasally (i.n.) with OVA (10 mg, 50 ml) and AAD
was assessed on day 16 [67]. Controls were sham sensitized to
saline.
NTHi infection model
NTHi (NTHi-289) glycerol stocks were plated onto chocolate
agar plates (Oxoid, SA, Australia), grown overnight (37uC, 5%
CO2), then washed off the plate and suspended in sterile PBS. To
determine the effects of infection, mice were inoculated i.t. with
5x10
5 CFU NTHi (in 30 ml PBS) during (Day 0) or after (Day 10)
OVA sensitization. Controls were infected but not exposed to
OVA. In preliminary studies we determined that this inoculum
induced an infection from which the mice recovered and could be
used to study the effects of infection on AAD.
Cellular inflammation
BALF was collected and processed as previously described [68].
Briefly, the leftlung was tied offand the right lung was washedtwice
with Hank’s buffered salt solution (700 ml, HBSS; Trace Scientific,
Noble Park, Vic, Australia). Cells were pelleted and resuspended in
red blood cell lysis buffer, washed and resuspended in HBSS, then
cytocentrifuged (300g, 5 min, ThermoFisher Scientific, Scoresby,
Vic, Australia) onto microscope slides. Blood smears were prepared
from a drop of wholeblood.BALFand bloodcells were stainedwith
May-Grunwald-Giemsa, and differential leukocyte counts were
enumerated using light microscopy [68].
Bacterial recovery
Right lobes of lungs, from which BALF had been obtained,
were aseptically removed and homogenized in 1ml of sterile PBS.
Figure 8. Early neutrophil influx is associated with enhanced neutrophil chemokine expression. To investigate the association between
early neutrophil influx and neutrophil chemokine responses, KC and MIP2 mRNA expression (on day 1 and 16, A) and protein levels (day 1 only, B) in
lung tissue were assessed. Data for the corresponding NTHi control groups were obtained at the same time point after infection as data from the
NTHi+OVA groups. ## p,0.01, # p,0.05 compared to Saline controls, ** p,0.01, * p,0.05 compared to OVA controls.
doi:10.1371/journal.ppat.1002244.g008
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sterile PBS, plated onto chocolate agar plates and incubated
overnight (37uC, 5% CO2). Colonies were enumerated and
bacterial numbers per right lung calculated.
Lung function
AHR was measured in response to increasing doses of
aerosolized methacholine, by whole body invasive plethysmogra-
phy as previously described [47]. Briefly, mice were anaesthetized
and tracheas were cannulated and attached to a ventilator.
Peak dynamic compliance and transpulmonary resistance were
assessed by analysis of pressure and flow waveforms following
challenge with increasing doses of aerosolized methacholine
(Sigma-Aldrich).
T cell cytokines
Supernatants from lung draining MLN T cells were restimu-
lated with OVA (200 mg/ml) or ethanol-killed NTHi (2610
7
CFU/ml) and cultured for six days (5% CO2,3 7 uC, 1x10
6 cells
per well). After culture supernatants containing soluble factors
were recovered and analyzed for IL-5, IFN-c, (BD Biosciences,
North Ride, NSW, Australia), IL-13, IL-17A and IL-22 (R&D
Systems, Minneapolis, MN, USA) by ELISA, according to
manufacturer’s instructions [69].
Figure 9. NTHi infection induces Th17 cell differentiation and IL-17 production from Th17 cells in neutrophilic AAD. Th17 cell
differentiation in lung tissues was examined by determination of the expression of the transcription factor ROR-ct (A). Th17 cell numbers and
proportions were quantified in lungs (B–C) and lymph nodes (D–E). Data for the corresponding NTHi control groups were obtained at the same time
point after infection as data from the NTHi+OVA groups. ## p,0.01 compared to Saline controls, ** p,0.01, * p,0.05 compared to OVA controls.
doi:10.1371/journal.ppat.1002244.g009
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Whole lungs were homogenized in RIPA buffer (1ml, Sigma-
Aldrich) and incubated on ice for 5 mins. Cells were pelleted
and the supernatant recovered and analyzed for KC and
MIP2 by ELISA, (R&D Systems), according to manufacturer’s
instructions.
Figure 10. NTHi infection induces early IL-17 production from lung macrophages and neutrophils in neutrophilic AAD. To determine
early cellular sources of IL-17, IL-17 producing macrophage (A–B) and neutrophil (C–D) numbers and proportions in lungs were assessed. IL-17 mRNA
was also assessed in isolated lung macrophages (E) and neutrophils (F). Data for the corresponding NTHi control groups were obtained at the same
time point after infection as data from the NTHi+OVA groups. ### p,0.001 compared to Saline controls, *** p,0.001, ** p,0.01 compared to OVA
controls.
doi:10.1371/journal.ppat.1002244.g010
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RNA was TRIZOL extracted from whole lung homogenates
according to manufacturer’s instructions (Invitrogen, Mount
Waverly, Vic, Australia). Target gene expression was determined
relative to the reference gene hypoxanthine-guanine phosoribosyl-
transferase (HPRT) [69]. Primers used were IL-17, Fwd 59-
aaacatgagtccagggagagcttt-39, Rev 59-actgagcttcccagatcacagagg-39;
ROR-ct, Fwd 59- ccgctgagagggcttcac-39, Rev 59- tgcaggagtaggc-
cacattaca-39; MIP2, Fwd 59- ctagctgcctgcctcattctac-39, Rev 59-
caacagtgtacyyacgcagacg-39; KC Fwd 59- cttggggacaccttttagca-39,
Rev 59- gctgggattcacctcaagaa-39; TGF-b Fwd 59- cccgaagcggac-
tactatgctaaa-39, Rev 59- ggtaacgccaggaattgttgctat-39; IL-10, Fwd
59-catttgaattccctgggtgagaag-39, Rev 59- gccttgtagacaccttggtcttgg-
39; and HPRT Fwd 59- aggccagactttgttggatttgaa-39, Rev 59-
caacttgcgctcatcttaggcttt-39.
Flow cytometry
Single cell suspensions of MLNs and collagenase-D digested
lungs were prepared. IL-17 producing cells were identified by
stimulation with phorbol 12-myristate 13-acetate (PMA, 0.1 mg/
Figure 11. NTHi infection-induced IL-17 is required for the induction of neutrophilic AAD and is partially responsible for the effects
of infection on T cell responses. To confirm the role of IL-17, anti-IL-17 monoclonal antibody was administered i.p. on days 11 and 13 of infection-
induced neutrophilic AAD, and AAD was analyzed (on day 16) (A). The effects on BALF neutrophil influx (B), and KC and MIP2 mRNA expression in
lung tissue (C) were assessed. # p,0.05 compared to OVA controls, *** p,0.001, * p,0.05 compared to isotype controls.
doi:10.1371/journal.ppat.1002244.g011
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Brefeldin A (8 mg/ml, Sigma-Aldrich) for 4 hours [70]. Cells were
incubated with Fc block for 15mins, then stained for surface
markers CD4, CD3, CD11b, Gr-1 (BD Bioscience), or F4/80
(eBioscience, San Diego, CA, USA), fixed with 4% paraformal-
dehyde (PFA), permeabilized with 0.1% saponin, and stained for
intracellular IL-17 (or isotype control rat IgG2a, eBioscience).
Tregs were identified using surface markers CD4, CD25 and a
staining kit for intracellular FoxP3 (or IgG2a isotype control)
according to manufacturer’s instructions (eBioscience). pDCs were
characterized as CD11c
lowCD11b
-B220
+, and mDCs character-
ized as CD11c
+CD11b
+B220
2 (BD Bioscience); using MHCII and
CD86 (R&D Systems) for activation and co-stimulation status. All
cells were analyzed using a FACS Canto (BD Bioscience) [47].
Lung macrophage and neutrophil separation and mRNA
isolation
Single cell suspensions of collagenase-D digested lung tissue
were prepared, and resuspended in red blood cell lysis buffer.
Resuspended cells were either incubated overnight (5% CO2,
37uC, 1x10
6 cells per well) and macrophages isolated by adherence
to culture plates; or were put through a mouse neutrophil
enrichment kit (Stemcell Technologies, Melbourne, Vic, Australia)
and neutrophils isolated by negative selection following manufac-
turer’s instructions. mRNA was purified from these macrophages
and neutrophils using a PureLink RNA mini kit (Invitrogen)
according to manufacturer’s instructions.
Depletion of IL-17 during infection-induced neutrophilic
AAD
Monoclonal anti-IL-17A neutralizing antibody (clone 50104, rat
IgG2a) was administered by i.p. injection (100 mg/mouse,
eBioscience) on days 11 and 13, and features of AAD were
assessed on day 16. Control groups were uninfected and treated
with anti-IL-17 or treated with IgG2a isotype control antibody
[47].
Statistics
Results are presented as mean 6 standard error of the mean
(SEM) from 6–8 mice, in duplicate. Significance was determined
by one-way ANOVA or Student t-test (GraphPad Software, CA,
USA).
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